| CEO |
Chang-jae Lee |
-
Head of ETC Division,
Daewoong Pharmaceutical
-
Head of Marketing Division,
Daewoong Pharmaceutical
- Executive Director, Daewoong
-
Executive Vice President,
Daewoong Pharmaceutical
-
Chief Executive Officer,
Daewoong Pharmaceutical (Current)
|
Mar 2021 |
Mar 2027 |
Registered |
| Seongsoo Park |
-
Medicinal Chemistry Master of Science (MS),
Seoul National Univesity, Korea
- Head of Daewoong America, Inc.
- Head of Nabota Business Division
-
Executive Vice President,
Daewoong Pharmaceutical
-
Chief Executive Officer,
Daewoong Pharmaceutical (Current)
|
Mar 2023 |
Mar 2026 |
Registered |
| Executive Director |
Eunkyeong Park |
-
Head of CH Marketing Division,
Daewoong Pharmaceutical
-
Head of ETC Marketing Division,
Daewoong Pharmaceutical
- Executive Director, Daewoong
|
Mar 2024 |
Mar 2027 |
Registered |
| Outside Director |
Youngmin Cho |
-
MD-Ph.D of Internal Medicine,
Seoul National University, Korea
-
Visiting professor,
University of British Columbia
-
Professor of Internal Medicine,
Seoul National University (Current)
|
Mar 2024 |
Mar 2027 |
Registered |
| Soonyong Kwon |
-
Ph.D. in Medicine, Graduate School of Medicine, Catholic
University
-
Visiting Scholar at UC San Diego (California, USA) and
Washington University in St. Louis, Missouri (WASH U)
-
The 11th Hospital Director of St. Paul’s Hospital, Catholic
University
-
The Founding Hospital Director of Eunpyeong St. Mary’s
Hospital
-
Professor of Orthopedic Surgery at Seoul St. Mary’s Hospital,
Catholic University (Current)
|
Mar 2025 |
Mar 2028 |
Registered |